What is Gleolan and what is it used for?
Gleolan, also known by its generic name 5-aminolevulinic acid, is a prescription medication used in neurosurgery [1]. It is indicated for use in patients with newly diagnosed, supratentorial malignant gliomas [1]. Gleolan works by being selectively taken up by tumor cells, where it is converted into a fluorescent compound called protoporphyrin IX [1]. This fluorescence allows surgeons to more easily identify and remove tumor tissue during surgery [1].
How is Gleolan administered and what is its mechanism of action?
Gleolan is administered orally as a solution [1]. The medication is taken approximately three hours before the patient undergoes tumor resection [1]. Once in the body, 5-aminolevulinic acid is metabolized to protoporphyrin IX, a fluorescent molecule that accumulates preferentially in malignant glioma cells [1]. This preferential accumulation enables tumor cells to fluoresce under specific light conditions during surgery, aiding in their visualization and resection [1].
What is the efficacy of Gleolan in glioma surgery?
Studies have shown that Gleolan improves the extent of tumor resection in patients with malignant gliomas [1]. By enhancing the visualization of tumor margins, surgeons are able to remove more tumor tissue [1]. This increased extent of resection is associated with improved progression-free survival [1].
What are the potential side effects of Gleolan?
The most common side effects reported with Gleolan include nausea, vomiting, and phototoxicity reactions [1]. Phototoxicity is a reaction to light, and patients treated with Gleolan are advised to avoid direct sunlight and bright indoor light for 48 hours after taking the medication [1]. Other reported side effects can include abdominal pain, constipation, headache, and dizziness [1].
How does Gleolan compare to other methods of tumor visualization?
Gleolan offers a fluorescence-guided approach to tumor resection, complementing standard surgical techniques like visual inspection and intraoperative imaging [1]. While other imaging techniques, such as MRI, are crucial for pre-operative planning and post-operative assessment, Gleolan provides real-time visualization of tumor margins during the surgical procedure itself [1]. This can be particularly beneficial in identifying infiltrative tumor borders that may not be apparent through other methods [1].
Are there any cost assistance programs or coupons for Gleolan?
Information regarding specific coupons or discount programs for Gleolan is not readily available through general medical information sources [1]. However, patients seeking financial assistance may be able to find information through the drug manufacturer's patient support programs or by consulting with their healthcare provider and hospital's financial assistance department [1]. These programs can sometimes offer co-pay assistance or other forms of support for eligible patients.
What is the regulatory status and approval timeline for Gleolan?
Gleolan received approval from the U.S. Food and Drug Administration (FDA) in 2017 [1]. Its approval was based on clinical trial data demonstrating its safety and efficacy in enhancing tumor visualization during glioma surgery [1].
What are the limitations and contraindications for Gleolan use?
Gleolan is contraindicated in patients with known hypersensitivity to 5-aminolevulinic acid or any of its components [1]. It is also not recommended for patients with certain types of porphyria [1]. The medication's use is limited to neurosurgical procedures for specific types of brain tumors, as outlined in its approved indications [1].
---
Sources:
1. https://www.gleolan.com/